Advertisement

Serum cystatin C, cystatin C level change and risk of atrial fibrillation

  • Odong Christopher
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Yiquan Huang
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Zhenyu Xiong
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Xiaodong Zhuang
    Correspondence
    Corresponding authors at: Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China.
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Xinxue Liao
    Correspondence
    Corresponding authors at: Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China.
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chung M.K.
        • Eckhardt L.L.
        • Chen L.Y.
        • Ahmed H.M.
        • Gopinathannair R.
        • Joglar J.A.
        • et al.
        Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association.
        Circulation. 2020; 141: e750-ee72
        • Ding Y.
        • Liu L.
        • Chen Z.
        • Li H.
        • Pan Y.
        • Wang J.
        • et al.
        Serum cystatin C predicts stroke clinical outcomes at 1 year independent of renal function.
        Front Neurol. 2021; 12676872
        • Angeli F.
        • Verdecchia P.
        • Savonitto S.
        • Arraiz G.
        • Zaninotto M.
        • Broccatelli A.
        • et al.
        Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
        EuroIntervention. 2015; 11: 757-764
        • Salgado J.V.
        • Souza F.L.
        • Salgado B.J.
        How to understand the association between cystatin C levels and cardiovascular disease: imbalance, counterbalance, or consequence?.
        J Cardiol. 2013; 62: 331-335
        • Zou L.X.
        • Sun L.
        • Nicholas S.B.
        • Lu Y.
        • K S.S.
        • Hua R.
        Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation.
        Eur J Intern Med. 2020; 80: 29-34
        • Rehm M.
        • Rothenbacher D.
        • Iacoviello L.
        • Costanzo S.
        • Tunstall-Pedoe H.
        • Fitton C.A.
        • et al.
        Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project.
        ESC Heart Fail. 2022; 9: 57-65
        • Rothenbacher D.
        • Rehm M.
        • Iacoviello L.
        • Costanzo S.
        • Tunstall-Pedoe H.
        • Belch J.J.F.
        • et al.
        Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project.
        BMC Med. 2020; 18: 300
      1. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. the ARIC investigators.
        Am J Epidemiol. 1989; 129: 687-702
        • Wang W.
        • Yuan R.
        • Korantzopoulos P.
        • Xu G.
        • Cui X.
        • Li G.
        • et al.
        Cystatin C and risk of atrial fibrillation in elderly hypertensive patients without chronic kidney disease.
        Int J Cardiol. 2016; 212: 262-264
        • Jin L.L.
        • You L.
        • Xie R.Q.
        Value of cystatin C in predicting atrial fibrillation recurrence after radiofrequency catheter ablation.
        J Geriatr Cardiol. 2018; 15: 725-731